Osaic Holdings
MYGN icon

Osaic Holdings’s Myriad Genetics MYGN Stock Holding History

Osaic Holdings’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$373K Buy
65,354
+4,154
+7% +$18.9K ﹤0.01% 3912
2026
Q1 		$275K Buy
61,200
+60,114
+5,535% +$313K ﹤0.01% 3882
2025
Q4 		$6.68K Sell
1,086
-28
-3% -$203 ﹤0.01% 6543
2025
Q3 		$7.3K Sell
1,114
-20
-2% -$119 ﹤0.01% 6548
2025
Q2 		$6.02K Sell
1,134
-1,008
-47% -$5.95K ﹤0.01% 6439
2025
Q1 		$19K Sell
2,142
-522
-20% -$6.27K ﹤0.01% 5402
2024
Q4 		$36.5K Sell
2,664
-458
-15% -$8.45K ﹤0.01% 4924
2024
Q3 		$85.5K Buy
3,122
+696
+29% +$18.8K ﹤0.01% 4343
2024
Q2 		$59.3K Buy
2,426
+42
+2% +$922 ﹤0.01% 4537
2024
Q1 		$50.8K Sell
2,384
-7,092
-75% -$152K ﹤0.01% 4746
2023
Q4 		$181K Sell
9,476
-6,648
-41% -$115K ﹤0.01% 4001
2023
Q3 		$259K Buy
16,124
+6,531
+68% +$124K ﹤0.01% 3806
2023
Q2 		$222K Buy
9,593
+380
+4% +$8.29K ﹤0.01% 3812
2023
Q1 		$214K Sell
9,213
-12,890
-58% -$262K ﹤0.01% 3816
2022
Q4 		$321K Buy
22,103
+288
+1% +$5.37K ﹤0.01% 3450
2022
Q3 		$417K Buy
21,815
+991
+5% +$22.7K ﹤0.01% 3066
2022
Q2 		$379K Buy
20,824
+1,459
+8% +$30.3K ﹤0.01% 3210
2022
Q1 		$488K Buy
19,365
+2,272
+13% +$58.1K ﹤0.01% 3244
2021
Q4 		$472K Sell
17,093
-5,418
-24% -$157K ﹤0.01% 3118
2021
Q3 		$726K Buy
22,511
+4,524
+25% +$150K ﹤0.01% 2648
2021
Q2 		$551K Sell
17,987
-1,988
-10% -$57.4K ﹤0.01% 2926
2021
Q1 		$609K Buy
19,975
+6,504
+48% +$185K ﹤0.01% 2672
2020
Q4 		$266K Sell
13,471
-618
-4% -$9.98K ﹤0.01% 3220
2020
Q3 		$184K Sell
14,089
-211
-1% -$2.67K ﹤0.01% 3327
2020
Q2 		$162K Buy
14,300
+4,815
+51% +$68.4K ﹤0.01% 3323
2020
Q1 		$136K Buy
+9,485
New +$200K ﹤0.01% 3216

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Osaic Holdings's MYGN Position: Q2 2026 in Review

Osaic Holdings increased its Myriad Genetics (MYGN) stake by 6.8% in Q2 2026, buying an estimated $18.9K and bringing the position to 65,354 shares worth $373K. The position accounts for ﹤0.01% of the portfolio, ranked #3912.

Osaic Holdings first reported a position in MYGN in Q1 2020 and has held it in 26 quarters since. The position peaked at $726K in Q3 2021. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Osaic Holdings held 65,354 shares of Myriad Genetics worth $373K as of Q2 2026.
  • Osaic Holdings bought 4,154 Myriad Genetics shares in Q2 2026, an estimated $18.9K.
  • Myriad Genetics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3912 holding.
  • Osaic Holdings first reported a position in Myriad Genetics in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Myriad Genetics position peaked at $726K in Q3 2021.
  • 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.